STAT+: Pharmalittle: We’re reading about a cancer vaccine, an experimental pancreatic cancer drug, and more

🇺🇸 STAT News Health (US) —
STAT+: Pharmalittle: We’re reading about a cancer vaccine, an experimental pancreatic cancer drug, and more

AI Summary

A personalized mRNA cancer vaccine reduced the risk of melanoma recurrence by 42% compared with standard treatment, according to the article. The health roundup also points to research on an experimental drug for pancreatic cancer.

A personalized mRNA cancer vaccine reduced the risk of disease recurrence in patients with melanoma by 42% compared to a standard treatment

Health melanoma cancer vaccine mRNA recurrence risk pancreatic cancer clinical research

Read original source →